» Articles » PMID: 11932782

Sphincter of Oddi Dysfunction: Pancreaticobiliary Sphincterotomy with Pancreatic Stent Placement Has a Lower Rate of Pancreatitis Than Biliary Sphincterotomy Alone

Overview
Journal Endoscopy
Date 2002 Apr 5
PMID 11932782
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Study Aims: Patients with suspected or documented sphincter of Oddi dysfunction (SOD) who undergo standard biliary sphincterotomy have high rates of post-procedure pancreatitis. Approximately 75% of such patients have elevated basal pressures of the pancreatic sphincter. Biliary sphincterotomy (BES) on its own leaves the pancreatic sphincter unablated and may cause transient edema which aggravates the increase in pancreatic sphincter pressure. Combined pancreaticobiliary therapy (PBR), using pancreatic stenting in addition to sphincterotomy may therefore be safer.

Patients And Methods: The endoscopic retrograde cholangiopancreatography (ERCP) database was queried for patients with successful double-duct sphincter of Oddi manometry (SOM) who underwent BES alone or PBR between 1994 and 1997. The endoscopist had decided on the technique to be used. From 1995 to 1997 there was a general trend to do PBR. Pancreatitis was defined according to established criteria.

Results: The post-ERCP pancreatitis rate among all 436 SOD patients was 19.7%, while 256 patients with normal SOM results had a pancreatitis rate of 12.9%. The use of combined PBR was associated with a lower frequency of pancreatitis compared with BES alone (needle-knife over pancreatic duct stent, 14/131 patients, 10.7 %; pull-type pancreaticobiliary sphincterotomy plus pancreatic stent, 15/78 patients, 19.2%; BES alone, 52/184 patients, 28.3%). Episodes of moderate and severe pancreatitis were seen more frequently in the BES group.

Conclusion: In SOD patients, post-ERCP pancreatitis rates remain high, but have improved with the addition of combined pancreaticobiliary sphincter therapy.

Citing Articles

Instant duodenal decompression after endoscopic retrograde cholangiopancreatography can effectively reduce the incidence of post-ERCP pancreatitis and hyperamylasemia.

Bi Y, Yan S, Zhou L, Sun Y, Zhang J Gastroenterol Rep (Oxf). 2024; 12:goae025.

PMID: 38586538 PMC: 10997411. DOI: 10.1093/gastro/goae025.


Risk factors for post‑retrograde cholangiopancreatography pancreatitis in patients with common bile duct stones: A meta‑analysis.

Zhou B, Zhao L, Xing X, Wang H, Kuwantai A, Chen K Exp Ther Med. 2023; 27(1):32.

PMID: 38125338 PMC: 10731401. DOI: 10.3892/etm.2023.12320.


Role of Tc-Mebrofenin Hepatobiliary Scintigraphy in the Diagnosis of Post Cholecystectomy Syndrome.

Sowmya S, Gupta A, Narayan M, Chauhan U, Jain J, Singla T World J Nucl Med. 2022; 21(3):231-235.

PMID: 36060090 PMC: 9436510. DOI: 10.1055/s-0042-1751038.


Impact of a Novel Oblique-Tip Papillotome for Biliary Cannulation during ERCP: A Nonrandomized Coarsened Exact Matching Study.

Imazu H, Ho S, Hino S, Goh K, Moriyama M, Sumiyama K Gastroenterol Res Pract. 2020; 2020:2417841.

PMID: 32454813 PMC: 7229551. DOI: 10.1155/2020/2417841.


Acute distal common bile duct angle is risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis in beginner endoscopist.

Han S, Kim D, Lee M, Park Y, Baek D, Kim G World J Clin Cases. 2020; 8(1):20-28.

PMID: 31970166 PMC: 6962061. DOI: 10.12998/wjcc.v8.i1.20.